724 J ournal of Natural Products, 2000, Vol. 63, No. 5
Notes
to 90:9:1) and preparative TLC (CHCl3/MeOH/NH4OH, 90:9:
1), affording protoemetine (4.8 mg), deoxytubulosine (83.9 mg),
protoemetinol (8.8 mg), neocephaeline (97.0 mg), 2′-N-(1′′-
deoxy-1′′-â-D-fructopyranosyl)cephaeline (25.5 mg), cephaeline
(1.39 g), and isocephaeline (109 mg). In the same way, the
following fractions were purified by a combination of MPLC
with CHCl3/MeOH/NH4OH (98:2:0.2 to 90:9:1) and preparative
TLC with CHCl3/MeOH/NH4OH (90:9:1) or C6H6/EtOAc/Et2NH
(2:7:1). Fraction 3 yielded deoxytubulosine (28.0 mg), neoceph-
aeline (28.6 mg), cephaeline (1.15 g), and isocephaeline (154
mg); fraction 4, 3 (224 mg), 4 (23.6 mg), 2′-N-(1′′-deoxy-1′′-â-
D-fructopyranosyl)cephaeline (4.7 mg), cephaeline (345 mg),
isocephaeline (899 mg), psychotrine (37.9 mg), and 10-O-
demethylcephaeline (24.5 mg); fraction 5, 3 (57.0 mg), 1 (10.9
mg), 4 (16.2 mg), cephaeline (10.2 mg), and isocephaeline (119
mg). The C2H4Cl2 layer (6.4 g) was also subjected to MPLC,
and elution with CHCl3/MeOH mixtures of the indicated that
the MeOH content gave 7 fractions: 1 (2%, 69.3 mg), 2 (2%,
245 mg), 3 (5%, 1.90 g), 4 (5-8%, 2.01 g), 5 (8%, 587 mg), 6
(8-20%, 826 mg), 7 (20%, 335 mg). Each fraction was purified
in a manner similar to that for the Et2O layer to yield
protoemetine (41.4 mg), cephaeline (1650 mg), isocephaeline
(985 mg), deoxytubulosine (26.1 mg), neocephaeline (16.1 mg),
2′-N-(1′′-deoxy-1′′-â-D-fructopyranosyl)cephaeline (74.9 mg),
psychotrine (596 mg), alangiside (96.0 mg), 3 (6.2 mg), 4 (3.4
mg), salsoline (2.8 mg), and 2 (3.0 mg). The known alkaloids
were identified by comparisons ([R]D, UV, IR, NMR, and MS)
with pure standards.
F igu r e 1. Selected NOESY correlations of 2.
-11b, and -14 were suggested by the NOESY correlations
between H-11b and H-14 and between H-1 and H2-15
(Figure 1). This assumption was supported by comparative
studies of its 13C NMR spectral data with those of antirhine
(5).12 Biogenetic considerations that the non-dopamine
portion of 2 originated from secologanin, and thereby the
chirality of C-2 should be S, allowed assignment of the
absolute stereochemistry of 2. Thus, alangine was deter-
mined to be structure 2.
The occurrence of 1 and 2 is of great interest from the
viewpoint of biosynthesis of Alangium alkaloids.13 Alkaloid
1 could be derived from tubulosine (3) or isotubulosine (4).
Two plausible mechanisms could be proposed for the
formation of 3 and 4. Two epimeric alkaloids might be
independently biosynthesized through condensation of a
protoemetine type alkaloid with tryptamine (or serotonin)
in a manner similar to the biosynthesis of deacetylipecoside
and deacetylisoipecoside.14 Another possibility is an oxida-
tion-hydrogenation mechanism as observed in the conver-
sion of (S)-reticuline to (R)-reticuline via the 1,2-dehydro-
reticulinium ion.15 In the latter case 1 should be an
intermediate between 3 and 4. Alkaloid 1 could also be
oxidized to 1′,2′,3′,4′-tetradehydrotubulosine in Pogonopus
speciosus.16 On the other hand, alkaloid 2 is the first
compound with a new basic skeleton, which could be
formed from 6, a common intermediate to 10-O-demethyl-
protoemetinol (7).17
1′,2′-Deh yd r otu bu losin e (1): amorphous powder; [R]18
D
+2.1° (c 0.42, MeOH); UV (MeOH) λmax (log ꢀ) 230sh (4.20),
291 (3.69), 328 (4.04), 370sh (3.67) nm; CD (MeOH) λmax (∆ ꢀ)
211 (+8.7), 223 (-2.1) nm; IR (KBr) νmax 3432, 2833, 2748,
1612, 1514 cm-1; 1H NMR (CD3OD) δ 1.00 (3H, t, J ) 7.5 Hz,
H3-13), 1.17 (1H, dt, J ) 13.5, 11.5 Hz, H-1), 1.24-1.32 (3H,
m, H-12, H2-R), 1.55 (1H, m, H-3), 1.81 (1H, m, H-2), 1.85 (1H,
dqd, J ) 13.5, 7.5, 3.0 Hz, H-12), 2.03 (1H, ddd, J ) 13.5, 4.0,
3.0 Hz, H-1), 2.10 (1H, t, J ) 11.5 Hz, H-4), 2.50 (1H, m, H-6),
2.65 (1H, dt, J ) 14.0, 4.0 Hz, H-7), 2.96 (2H, m, H2-4′), 2.99-
3.18 (3H, m, H-6, H-7, H-11b), 3.11 (1H, dd, J ) 11.5, 4.0 Hz,
H-4), 3.27 (3H, s, 10-OMe), 3.72 (3H, s, 9-OMe), 3.78 (1H, m,
H-3′), 3.92 (1H, dt, J ) 15.0, 7.0 Hz, H-3′), 6.19 (1H, s, H-11),
6.61 (1H, s, H-8), 6.90 (1H, dd, J ) 8.5, 2.5 Hz, H-7′), 6.92
(1H, dd, J ) 2.5, 0.5 Hz, H-5′), 7.28 (1H, dd, J ) 8.5, 0.5 Hz,
H-8′); 13C NMR (CD3OD) δ 11.5 (C-13), 20.5 (C-4′), 24.5 (C-
12), 29.3 (C-7), 30.8 (C-R), 37.2 (C-1), 42.0 (C-2), 43.4 (C-3),
47.3 (C-3′), 53.6 (C-6), 56.1 (10-OMe), 56.4 (9-OMe), 61.8 (C-
4), 63.6 (C-11b), 104.0 (C-5′), 109.1 (C-11), 113.1 (C-8), 114.4
(C-8′), 118.7 (C-7′), 119.4 (C-4′a), 127.0 (C-5′a), 127.5 (C-7a),
130.3 (C-11a), 130.6 (C-9′a), 135.5 (C-8′a), 148.6 (C-10), 149.2
(C-9), 153.0 (C-6′), 166.4 (C-1′); NOESY correlations H-11/OMe
(δ 3.27); H-11/H-1 (δ 2.03); H-8/OMe (δ 3.78); H-8/H-7 (δ 2.65);
EIMS m/z 473 [M]+, 272, 270, 244, 201, 200, 192, 176, 146;
HR-EIMS m/z 473.2648 (calcd for C29H35N3O3, 473.2680).
Exp er im en ta l Section
Gen er a l Exp er im en ta l P r oced u r es. UV spectra were
recorded on a Shimadzu UV-240 spectrophotometer and IR
spectra on a Shimadzu FTIR-8200 spectrophotometer. Optical
rotations were measured on a J asco DIP-370 digital polarim-
eter and CD spectra on a Shimadzu-AVIV 62 A DS circular
dichroism spectrometer. 1H (500 MHz) and 13C (125 MHz)
NMR spectra were recorded on a Varian VXR-500 spectrom-
eter with TMS as an internal standard. MS and HRMS were
obtained with a Hitachi M-4100 mass spectrometer. MPLC
was carried out with Wakogel FC-40. TLC was performed on
precoated Kieselgel 60F254 plates (Merck).
P la n t Ma ter ia l. The dried fruits of Alangium lamarckii,
collected in India, were purchased from Mikuni, Osaka, J apan.
A voucher specimen (KPFY-921) is deposited in our laboratory.
Extr a ction a n d Isola tion . The dried fruits (4.5 kg) of A.
lamarckii were crushed and extracted with hot MeOH, and
the extracts were fractionated as described previously.2 A part
(426 g) of the residue (556 g) from the H2O layers was
redissolved in H2O, basified with Na2CO3, and extracted with
Et2O and C2H4Cl2 successively. The residue (8.8 g) from the
Et2O layer was subjected to MPLC, and elution with CHCl3/
MeOH mixtures of the indicated MeOH content gave 5
fractions: 1 (2%, 171 mg), 2 (2-5%, 2.49 g), 3 (8%, 1.75 g), 4
(10-15%, 2.44 g), 5 (20-25%, 192 mg). Fraction 1 was purified
by preparative TLC (CHCl3/MeOH/NH4OH, 85:15:1.5) to afford
protoemetine (15.2 mg) and deoxytubulosine (11.6 mg). Frac-
tion 2 was purified by MPLC (CHCl3/MeOH/NH4OH, 98:2:0.2
Ala n gin e (2): amorphous powder; [R]30 -0.95° (c 0.21,
D
MeOH); [R]23 -2.5° (c 0.20, CHCl3); UV (MeOH) λmax (log ꢀ)
D
225sh (3.74), 285 (3.45) nm; CD (MeOH) λmax (∆ ꢀ) 206 (-4.8),
219 (+1.4), 235 (+0.7) nm; IR (KBr) νmax 3569, 2975, 1613,
1516, 1457 cm-1; 1H NMR (CDCl3) δ 1.68 (1H, m, H-2), 1.71-
1.81 (2H, m, H2-3), 2.14 (2H, m, H2-1), 2.35 (1H, m, H-14), 2.71
(1H, m, H-7), 2.84 (2H, m, H2-4), 3.07 (1H, m, H-6), 3.09 (1H,
m, H-7), 3.19 (1H, m, H-6), 3.57 (1H, dd, J ) 10.5, 7.5 Hz,
H-15), 3.79 (1H, dd, J ) 10.5, 4.5 Hz, H-15), 3.86 (3H, s, OMe),
4.07 (1H, m, H-11b), 5.17 (1H, ddd, J ) 17.0, 1.5, 0.5 Hz, H-12),
5.23 (1H, dd, J ) 10.0, 1.5 Hz, H-12), 5.60 (1H, ddd, J ) 17.0,
10.0, 9.5 Hz, H-13), 6.57 (1H, s, H-8), 6.77 (1H, s, H-11); 13C
NMR (CDCl3) δ 25.0 (C-7), 27.4 (C-3), 31.0 (C-2), 31.5 (C-1),
47.8 (C-4), 49.0 (C-14), 50.7 (C-6), 55.9 (OMe), 56.8 (C-11b),
63.5 (C-15), 111.0 (C-8), 111.2 (C-11), 118.8 (C-12), 124.5 (C-
7a), 127.0 (C-11a), 138.1 (C-13), 144.5 (C-10), 145.7 (C-9);
NOESY correlations H-1/H-11; H2-7/H-8; H2-15/H2-1; H-11b/
H-14; H-14/H-12 (δ 5.23); OMe/H-8; H-12 (δ 5.17)/H-14; EIMS
m/z 303 [M]+, 302, 272, 232, 230, 191, 178, 176; HREIMS m/z
303.1858 (calcd for C18H25NO3, 303.1836).
Red u ction of 1′,2′-Deh yd r otu bu losin e (1). A methanolic
solution (1 mL) of 1′,2′-dehydrotubulosine (1) (4.9 mg) was